Your browser doesn't support javascript.
loading
The association between social support and chemotherapy-related toxicity in older patients with cancer.
Shahrokni, Armin; Sun, Can-Lan; Tew, William P; Mohile, Supriya Gupta; Ma, Huiyan; Owusu, Cynthia; Klepin, Heidi D; Gross, Cary Philip; Lichtman, Stuart M; Gajra, Ajeet; Katheria, Vani; Cohen, Harvey Jay; Hurria, Arti.
Afiliação
  • Shahrokni A; Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, NY, USA. Electronic address: shahroka@mskcc.org.
  • Sun CL; Department of Supportive Care Medicine, City of Hope, Duarte, CA, USA.
  • Tew WP; Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, NY, USA.
  • Mohile SG; Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
  • Ma H; Department of Population Sciences, City of Hope, Duarte, CA, USA.
  • Owusu C; Department of Medicine, Case Western Reserve University, Cleveland, OH, USA.
  • Klepin HD; Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Gross CP; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Lichtman SM; Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, NY, USA.
  • Gajra A; ICON Clinical Research, North Wales, PA, USA.
  • Katheria V; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA.
  • Cohen HJ; Center for the Study of Aging & Human Development, Duke University Medical Center, Durham, NC, USA.
  • Hurria A; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA.
J Geriatr Oncol ; 11(2): 274-279, 2020 03.
Article em En | MEDLINE | ID: mdl-31501014
ABSTRACT

OBJECTIVES:

The goal of this study was to evaluate the relationship between social support (SS) and grade 3-5 chemotherapy-related toxicities among older adults with cancer.

METHODS:

This is a secondary analysis of a prospective longitudinal study of patients aged 65+ with solid cancer which led to the development of a predictive model for grade 3-5 chemotherapy-related toxicity (the Cancer and Aging Research Group [CARG] Chemotherapy Toxicity Risk Score). SS was measured by a modified version of Medical-Outcome Study-Social Support Survey and grade 3-5 hematological and non-hematological toxicities were captured and graded using CTCAE version 3.0. Patients were categorized into those with poor (SS score ≤ 75) and good SS (score of 76-100). Multivariate polychotomous logistic regression was used to examine the associations between SS and chemotherapy-related toxicity with adjustment for the CARG Toxicity Risk Score.

RESULTS:

Compared to patients with good SS, those with poor SS were less likely to have grade 3-5 toxicity, especially for non-hematological toxicity (adjusted OR = 0.52, p = .02). Patients who did not have someone to take them to the doctor "most" or "all of the time" were less likely to have grade 3-5 non-hematological toxicity compared to patients who had someone to take them to the doctor most or all of the time (adjusted OR = 0.32, p = .02).

CONCLUSION:

Our study showed that patients with poor SS, especially those with less availability of someone to take them to doctors were less likely to have a documented grade 3-5 non-hematological toxicity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: J Geriatr Oncol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: J Geriatr Oncol Ano de publicação: 2020 Tipo de documento: Article